EUVIMEDEUVIMED entdecken
Crossref

Towards patient-centered HIV drug resistance testing services in China: A discrete choice experiment

Qingxian Song iD, Qianqian Shen, Tengxiao Long, Yingni Yu, Shu Su iD

International Journal of STD & AIDS · 2026-11 · 37 (13) · 1247-1256

DOI: 10.1177/09564624261480307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of STD & AIDS, online erschienen am 23.08.2026. Verfasst von Qingxian Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: HIV Infections, Drug Resistance, Viral, Patient Preference, Anti-HIV Agents. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Kuanren Talent programs of the second affiliated hospital of Chongqing Medical University, Chongqing Public Health Talent Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HIV drug resistance testing plays an important role in optimizing antiretroviral therapy, yet routine testing remains limited in China. This study applied a discrete choice experiment to evaluate patient preferences and willingness-to-pay for HIV drug resistance testing; to inform patient-centered implementation strategies for HIV drug resistance testing.

Methods

Between April and June 2025, people living with HIV were recruited from community healthcare centers in China. Mixed logit models and latent class analysis were used to quantify attribute trade-offs, identify preference heterogeneity, and estimate willingness-to-pay across clinical and demographic subgroups.

Results

Among 204 participants, out-of-pocket cost was the dominant barrier to uptake, accounting for 62.3% of overall decision importance. Testing after treatment failure ( β = 0.862), and doctor recommendation ( β = 0.519) were primary determinants of choice (all p < 0.001). Combined testing ( p = 0.037), shorter waiting time (3 days: p = 0.008), and high accuracy ( p = 0.031) also significantly increased testing preference. Latent class analysis identified two distinct subgroups. Class 1 (failure-driven) prioritized testing after treatment failure ( β = 3.547) but showed a negative preference for combined testing and high accuracy (all p < 0.05). Class 2 (service-oriented) strongly valued doctor recommendation and high accuracy (all p < 0.01). Older participants (≥50 years old) had a higher willingness-to-pay for doctor recommendation than the younger (240.2 vs 115.7 CNY), while younger showed higher WTP for combined testing and high accuracy.

Conclusions

Reducing financial barriers, strengthening provider recommendations, and tailoring testing services to different patient preference patterns may improve HIV drug resistance testing uptake. These findings support patient-centered implementation strategies to promote earlier and more routine HIV drug resistance testing in China.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsDrug Resistance, ViralPatient PreferenceAnti-HIV AgentsHIV TestingPatient-Centered CareChoice BehaviorHumansFemaleChinaMaleAdultMiddle Aged

Stichwörter der Autor:innen

HIV drug resistanceantiretroviral therapydiscrete choice experimentimplementation sciencepatient preferenceswillingness-to-pay

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of HIV Prevention and Control, Chongqing Yuzhong Center for Disease Control and Prevention, Chongqing, China.

ORCID-Profile: Qingxian Song, Shu Su

Förderung

  • National Natural Science Foundation of China
  • Kuanren Talent programs of the second affiliated hospital of Chongqing Medical University
  • Chongqing Public Health Talent Program
  • The joint project of the Chongqing CDC and Science and Technology Bureau

Zitieren

APA

Song, Q., Shen, Q., Long, T., Yu, Y., & Su, S. (2026). Towards patient-centered HIV drug resistance testing services in China: A discrete choice experiment. International Journal of STD & AIDS, 37(13), 1247-1256. https://doi.org/10.1177/09564624261480307

Vancouver

Song Q, Shen Q, Long T, Yu Y, Su S. Towards patient-centered HIV drug resistance testing services in China: A discrete choice experiment. International Journal of STD & AIDS. 2026;37(13):1247-1256. doi:10.1177/09564624261480307

BibTeX
@article{Song2026,
  author = {Song, Qingxian and Shen, Qianqian and Long, Tengxiao and Yu, Yingni and Su, Shu},
  title = {Towards patient-centered HIV drug resistance testing services in China: A discrete choice experiment},
  journal = {International Journal of STD & AIDS},
  year = {2026},
  volume = {37},
  number = {13},
  pages = {1247--1256},
  doi = {10.1177/09564624261480307}
}
Kostenlos starten →